ANNOUNCEMENT

Save $150 on MedCity CONVERGE Healthcare Innovation Summit July 9-10 in Philadelphia. Offer ends July 8..

Topic: PTC Therapeutics

Late-stage cystic fibrosis, muscular dystrophy drug raises $30 million

Late-stage cystic fibrosis, muscular dystrophy drug raises $30 million

July 23, 2012 12:08 pm by | 3 Comments

A biopharmaceutical company with a cystic fibrosis drug in late-stage development has raised $30 million, according to a company statement. It was about $10 million less than the original funding ... Read more
Drug developer with phase 3 cystic fibrosis treatment raising $40 million

Drug developer with phase 3 cystic fibrosis treatment raising $40 million

June 14, 2012 9:13 pm by | 0 Comments

A drug developer that recently reported positive phase 3 results for its cystic fibrosis treatment for a severe form of the genetic disorder is raising $40 million in equity, according ... Read more
PTC Therapeutics gets $5 million drug development award

PTC Therapeutics gets $5 million drug development award

December 22, 2011 12:09 pm by | 0 Comments

PTC Therapeutics has received a $5 million Seeding Drug Discovery award from UK charity Wellcome Trust to support the development of small-molecule drugs to battle life-threatening infections caused by multi-drug-resistant, ... Read more
PTC Therapeutics licensing agreement with Roche valued up to $490 million

PTC Therapeutics licensing agreement with Roche valued up to $490 million

November 29, 2011 1:16 pm by | 0 Comments

PTC Therapeutics has agreed to a licensing deal with Swiss pharmaceutical firm Roche for its spinal muscular atrophy program that could be worth as much as $490 million.Under the terms ... Read more